Non-steroidal anti-inflammatory drugs and covid-19
Non-steroidal anti-inflammatory drugs and covid-19
Emerging evidence suggests that the most serious complications of covid-19 are sepsis and cardiovascular or respiratory complications. They occur predominantly in elderly people and those with underlying health conditions.1 Does use of non-steroidal anti-inflammatory drugs (NSAIDs) increase these risks? We don’t know for certain, but additional risks are plausible on the current balance of evidence.
Little, Paul
1bf2d1f7-200c-47a5-ab16-fe5a8756a777
27 March 2020
Little, Paul
1bf2d1f7-200c-47a5-ab16-fe5a8756a777
Little, Paul
(2020)
Non-steroidal anti-inflammatory drugs and covid-19.
The BMJ, 368 (368), [m1185].
(doi:10.1136/bmj.m1185).
Abstract
Emerging evidence suggests that the most serious complications of covid-19 are sepsis and cardiovascular or respiratory complications. They occur predominantly in elderly people and those with underlying health conditions.1 Does use of non-steroidal anti-inflammatory drugs (NSAIDs) increase these risks? We don’t know for certain, but additional risks are plausible on the current balance of evidence.
Text
Non-steroidal anti-inflammatory drugs and covid-19
- Version of Record
Available under License Other.
More information
Published date: 27 March 2020
Identifiers
Local EPrints ID: 439206
URI: http://eprints.soton.ac.uk/id/eprint/439206
ISSN: 0959-8138
PURE UUID: 7c1e58a5-482a-4f16-815b-1432d4933e30
Catalogue record
Date deposited: 07 Apr 2020 16:30
Last modified: 12 Jul 2024 01:35
Export record
Altmetrics
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
